Display options
Cite
Vega FM, Colmenero-Repiso A, Gómez-Muñoz MA, et al. Corrigendum to 'CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours' [EBioMedicine 49 (2019) 82-95]. EBioMedicine. 2020;53:102668doi: 10.1016/j.ebiom.2020.102668.
Vega, F. M., Colmenero-Repiso, A., Gómez-Muñoz, M. A., Rodríguez-Prieto, I., Aguilar-Morante, D., Ramírez, G., Márquez, C., Cabello, R., & Pardal, R. (2020). Corrigendum to 'CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours' [EBioMedicine 49 (2019) 82-95]. EBioMedicine, 53102668. https://doi.org/10.1016/j.ebiom.2020.102668
Vega, Francisco M, et al. "Corrigendum to 'CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours' [EBioMedicine 49 (2019) 82-95]." EBioMedicine vol. 53 (2020): 102668. doi: https://doi.org/10.1016/j.ebiom.2020.102668
Vega FM, Colmenero-Repiso A, Gómez-Muñoz MA, Rodríguez-Prieto I, Aguilar-Morante D, Ramírez G, Márquez C, Cabello R, Pardal R. Corrigendum to 'CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours' [EBioMedicine 49 (2019) 82-95]. EBioMedicine. 2020 Mar;53:102668. doi: 10.1016/j.ebiom.2020.102668. Epub 2020 Feb 25. PMID: 32109836; PMCID: PMC7044712.
Copy Download .nbib Format: NLM
Share it on

EBioMedicine. 2020 Mar;53:102668. doi: 10.1016/j.ebiom.2020.102668. Epub 2020 Feb 25.

Corrigendum to 'CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours' [EBioMedicine 49 (2019) 82-95].

EBioMedicine

Francisco M Vega, Ana Colmenero-Repiso, María A Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal

Affiliations

  1. Dpto. de Biología Celular, Universidad de Sevilla and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41012 Seville, Spain. Electronic address: [email protected].
  2. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla and Dpto. de Fisiología Médica y Biofísica, Universidad de Sevilla 41013 Seville, Spain.
  3. Unidad de Oncología Pediátrica, Hospital Universitario Virgen del Rocío, Spain.
  4. Unidad de Cirugía Pediátrica, Hospital Universitario Virgen del Rocío, Spain.
  5. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla and Dpto. de Fisiología Médica y Biofísica, Universidad de Sevilla 41013 Seville, Spain. Electronic address: [email protected].

PMID: 32109836 PMCID: PMC7044712 DOI: 10.1016/j.ebiom.2020.102668

[No abstract available.]

Publication Types